A method for quantification of human transporter proteins by liquid chromatography–tandem mass spectrometry

[1]  Kunal S. Taskar,et al.  Physiologically-Based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-Drug Interactions. , 2021, Current drug metabolism.

[2]  G. Marko‐Varga,et al.  Optimization of sample preparation for transporter protein quantification in tissues by LC–MS/MS , 2019, Journal of pharmaceutical and biomedical analysis.

[3]  D. Bedwell,et al.  Development of a rapid and sensitive multiple reaction monitoring proteomic approach for quantification of transporters in human liver tissue. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Caroline A. Lee,et al.  Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics , 2016, Drug Metabolism and Disposition.

[5]  T. Terasaki,et al.  Large‐scale multiplex absolute protein quantification of drug‐metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH‐MS: Comparison with MRM/SRM and HR‐MRM/PRM , 2016, Proteomics.

[6]  P. Cutler,et al.  The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development , 2015, Proteomics. Clinical applications.

[7]  Sanjay K. Nigam,et al.  What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.

[8]  A. Paulick,et al.  LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins. , 2013, Journal of pharmaceutical and biomedical analysis.

[9]  L Zhang,et al.  Transporter Studies in Drug Development: Experience to Date and Follow‐Up on Decision Trees From the International Transporter Consortium , 2013, Clinical pharmacology and therapeutics.

[10]  S-M Huang,et al.  Transporters in Drug Development and Clinical Pharmacology , 2013, Clinical pharmacology and therapeutics.

[11]  M Jamei,et al.  ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport‐Mediated PK and DDIs in Humans , 2013, Clinical pharmacology and therapeutics.

[12]  K. Brouwer,et al.  In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development , 2013, Clinical pharmacology and therapeutics.

[13]  Y. Lai,et al.  Interindividual Variability in Hepatic Expression of the Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2): Quantification by Liquid Chromatography/Tandem Mass Spectrometry , 2012, Drug Metabolism and Disposition.

[14]  N. Sadagopan,et al.  Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues. , 2012, Analytica chimica acta.

[15]  Tetsuya Terasaki,et al.  Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography. , 2011, Journal of pharmaceutical sciences.

[16]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.